News

A generic version of GlaxoSmithKline’s Lamictal ODT, the antiepileptic drug is indicated for the treatment of epilepsy and bipolar disorder. The company, which is the first to submit

The collaboration is focused on the development of a new generation of steroids and steroids related pharmaceuticals for rapid subcutaneous absorption. PharmaNova’s NovaSperse nanoparticle technology will be leveraged

Presenting a set of recommendations to the country’s union commerce ministry, the domestic makers claimed that unrestricted imports have threatened the survival of their businesses, as reported by

NICE chief executive Sir Andrew Dillon said there is evidence to suggest that bosutinib was considered clinically effective for the treatment of CML. However, the manufacturer had provided

By binding to inert resins, the enzymes are immobilized facilitating separation from a reaction mixture and allowing for use under diverse conditions and re-use at a commercial scale.

The Swiss agency for therapeutic products, Swissmedic, cleared tofacitinib 5mg and 10mg twice-daily (BID) as monotherapy or combination therapy along with a disease modifying non-biologic antirheumatic agent (DMARD)

These supplements help in improving the metabolism and restore the body’s ability to naturally regulate weight. Vitality Health & Wellness Dr Rapkin said that the natural, nutritional supplements

Planning to raise the financing through a private equity funding arrangement, the company is already in discussions with some financial institutional players. Roselabs executive Zameer Agarwal was quoted

The new plant, which has been inspected by the Medicines and Healthcare products Regulatory Agency (MHRA), is intended to provide access to clinical manufacturing capabilities for all the